Drug class
Racetam nootropic; cyclic GABA derivative and neuromodulator
Mechanism of action
The mechanism is not fully established. Piracetam modulates neuronal membrane fluidity and membrane-associated signalling and can influence neurotransmission and synaptic plasticity. It does not act as a conventional GABA receptor agonist despite its structural relationship to GABA.
General use cases
- Treatment of cortical myoclonus in adults, as an adjunct to other anti-myoclonic therapies, under the UK product label.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
